Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-10-09 5:20 pm Unchanged |
2020-10-07 | 13D | XOMA Corporation XOMA |
BIOTECHNOLOGY VALUE FUND L P | 4,182,243 38.000% |
0 (Unchanged) |
Filing History |
| 2020-10-08 5:26 pm Purchase |
2020-10-06 | 13D | FIVE PRIME THERAPEUTICS INC FPRX |
BIOTECHNOLOGY VALUE FUND L P | 8,364,353 22.800% |
581,352 (+7.47%) |
Filing History |
| 2020-10-05 5:26 pm Purchase |
2020-10-01 | 13G | NOVUS THERAPEUTICS INC NVUS |
BIOTECHNOLOGY VALUE FUND L P | 195,326 15.600% |
195,326 (New Position) |
Filing History |
| 2020-09-23 5:28 pm Purchase |
2020-09-21 | 13D | XOMA Corporation XOMA |
BIOTECHNOLOGY VALUE FUND L P | 4,182,243 38.000% |
156,086 (+3.88%) |
Filing History |
| 2020-08-25 5:27 pm Purchase |
2020-08-21 | 13D | Kymera Therapeutics, Inc. KYMR |
BIOTECHNOLOGY VALUE FUND L P | 2,630,662 5.900% |
2,630,662 (New Position) |
Filing History |
| 2020-08-25 12:32 pm Unchanged |
2020-08-25 | 13D | PRINCIPIA BIOPHARMA INC PRNB |
BIOTECHNOLOGY VALUE FUND L P | 5,231,900 15.700% |
0 (Unchanged) |
Filing History |
| 2020-08-19 1:49 pm Purchase |
2020-08-17 | 13G | PRINCIPIA BIOPHARMA INC PRNB |
BIOTECHNOLOGY VALUE FUND L P | 5,231,900 15.700% |
3,515,166 (+204.76%) |
Filing History |
| 2020-07-20 4:35 pm Purchase |
2020-07-08 | 13G | Therapeutics Acquisition Corp. RACA |
BIOTECHNOLOGY VALUE FUND L P | 1,000,000 5.900% |
1,000,000 (New Position) |
Filing History |
| 2020-07-20 4:22 pm Purchase |
2020-07-10 | 13D | Inventiva S.A. IVA |
BIOTECHNOLOGY VALUE FUND L P | 7,958,138 20.700% |
7,958,138 (New Position) |
Filing History |
| 2020-07-16 5:11 pm Purchase |
2020-07-06 | 13G | UNUM THERAPEUTICS INC UMRX |
BIOTECHNOLOGY VALUE FUND L P | 4,154,000 9.990% |
4,154,000 (New Position) |
Filing History |
| 2020-06-29 6:25 pm Purchase |
2020-06-19 | 13G | Repare Therapeutics Inc. RPTX |
BIOTECHNOLOGY VALUE FUND L P | 1,944,546 5.300% |
1,944,546 (New Position) |
Filing History |
| 2020-06-26 5:28 pm Purchase |
2020-06-16 | 13G | Celldex Therapeutics, Inc. CLDX |
BIOTECHNOLOGY VALUE FUND L P | 2,740,000 7.200% |
2,740,000 (New Position) |
Filing History |
| 2020-06-25 5:13 pm Purchase |
2020-06-15 | 13G | Forte Biosciences, Inc. FBRX |
BIOTECHNOLOGY VALUE FUND L P | 43,599 9.990% |
43,599 (New Position) |
Filing History |
| 2020-06-22 5:23 pm Purchase |
2020-06-18 | 13G | IDEAYA Biosciences, Inc. IDYA |
BIOTECHNOLOGY VALUE FUND L P | 3,224,172 11.000% |
1,787,743 (+124.46%) |
Filing History |
| 2020-06-22 5:17 pm Purchase |
2020-06-16 | 13G | Xenon Pharmaceuticals Inc. XENE |
BIOTECHNOLOGY VALUE FUND L P | 3,516,851 10.100% |
860,794 (+32.41%) |
Filing History |
| 2020-06-22 4:36 pm Purchase |
2020-06-11 | 13G | Curis, Inc. CRIS |
BIOTECHNOLOGY VALUE FUND L P | 182,500 7.200% |
182,500 (New Position) |
Filing History |